1. |
Pape R, Spuur K, Umo P. Exploring correlations between the breast density of the women of Papua New Guinea and breast cancer risk factors. Radiography (Lond), 2019, 25(4): e79-e87. doi: 10.1016/j.radi.2019.02.001.
|
2. |
Engmann NJ, Golmakani MK, Miglioretti DL, et al. Population-attributable risk proportion of clinical risk factors for breast cancer. JAMA Oncol, 2017, 3(9): 1228-1236.
|
3. |
Burstein HJ, Curigliano G, Loibl S, et al. Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019. Ann Oncol, 2019, 30(10): 1541-1557.
|
4. |
Conforti F, Pala L, Sala I, et al. Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis. BMJ, 2021, 375: e066381. doi: 10.1136/bmj-2021-066381.
|
5. |
Elsamany S, Alzahrani A, Abozeed WN, et al. Mammographic breast density: predictive value for pathological response to neoadjuvant chemotherapy in breast cancer patients. Breast, 2015, 24(5): 576-581.
|
6. |
Castaneda CA, Flores R, Rojas K, et al. Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinoma. Hematol Oncol Stem Cell Ther, 2014, 7(4): 149-156.
|
7. |
Skarping I, Förnvik D, Sartor H, et al. Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer. BMC Cancer, 2019, 19(1): 1272. doi: 10.1186/s12885-019-6485-4.
|
8. |
Skarping I, Förnvik D, Heide-Jørgensen U, et al. Mammographic density changes during neoadjuvant breast cancer treatment: NeoDense, a prospective study in Sweden. Breast, 2020, 53: 33-41.
|
9. |
Ogston KN, Miller ID, Payne S, et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast, 2003, 12(5): 320-327.
|
10. |
Symmans WF, Peintinger F, Hatzis C, et al. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol, 2007, 25(28): 4414-4422.
|
11. |
Gemici AA, Bayram E, Hocaoglu E, et al. Comparison of breast density assessments according to BI-RADS 4th and 5th editions and experience level. Acta Radiol Open, 2020, 9(7): 2058460120937381. doi: 10.1177/2058460120937381.
|
12. |
Bell RJ. Mammographic density and breast cancer screening. Climacteric, 2020, 23(5): 460-465.
|
13. |
Hur YM. Genetic and environmental etiology of the relationship between childhood hyperactivity/inattention and conduct problems in a South Korean twin sample. Twin Res Hum Genet, 2015, 18(3): 290-297.
|
14. |
Hodis HN, Sarrel PM. Menopausal hormone therapy and breast cancer: what is the evidence from randomized trials? Climacteric, 2018, 21(6): 521-528.
|
15. |
Brand JS, Czene K, Eriksson L, et al. Influence of lifestyle factors on mammographic density in postmenopausal women. PLoS One, 2013, 8(12): e81876. doi: 10.1371/journal.pone.0081876.
|
16. |
Rusiecki JA, Denic-Roberts H, Byrne C, et al. Serum concentrations of DDE, PCBs, and other persistent organic pollutants and mammographic breast density in Triana, Alabama, a highly exposed population. Environ Res, 2020, 182: 109068. doi: 10.1016/j.envres.2019.109068.
|
17. |
林灿洁, 钟声学, 邓文忠. 乳腺密度与乳腺癌保乳术后局部复发的关系探讨. 现代肿瘤医学, 2016, 24(11): 1739-1741.
|
18. |
Knight JA, Blackmore KM, Fan J, et al. The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study. Breast Cancer Res, 2018, 20(1): 23. doi: 10.1186/s13058-018-0948-4.
|
19. |
Huo CW, Chew G, Hill P, et al. High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium. Breast Cancer Res, 2015, 17(1): 79. doi: 10.1186/s13058-015-0592-1.
|
20. |
Cox TR, Erler JT. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech, 2011, 4(2): 165-178.
|
21. |
Liu D, Chua CK, Leong KF. A mathematical model for fluid shear-sensitive 3D tissue construct development. Biomech Model Mechanobiol, 2013, 12(1): 19-31.
|
22. |
Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov, 2019, 18(2): 99-115.
|
23. |
Lovitt CJ, Shelper TB, Avery VM. Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins. BMC Cancer, 2018, 18(1): 41. doi: 10.1186/s12885-017-3953-6.
|
24. |
Kim HW, Park JE, Baek M, et al. Matrix metalloproteinase-1 (MMP1) upregulation through promoter hypomethylation enhances tamoxifen resistance in breast cancer. Cancers (Basel), 2022, 14(5): 1232. doi: 10.3390/cancers14051232.
|
25. |
Qin X, Lv X, Li P, et al. Matrix stiffness modulates ILK-mediated YAP activation to control the drug resistance of breast cancer cells. Biochim Biophys Acta Mol Basis Dis, 2020, 1866(3): 165625. doi: 10.1016/j.bbadis.2019.165625.
|
26. |
Kleinstern G, Scott CG, Tamimi RM, et al. Association of mammographic density measures and breast cancer “intrinsic" molecular subtypes. Breast Cancer Res Treat, 2021, 187(1): 215-224.
|